EP1165123A4 - 48 menschliche sekretierte proteine - Google Patents

48 menschliche sekretierte proteine

Info

Publication number
EP1165123A4
EP1165123A4 EP00916584A EP00916584A EP1165123A4 EP 1165123 A4 EP1165123 A4 EP 1165123A4 EP 00916584 A EP00916584 A EP 00916584A EP 00916584 A EP00916584 A EP 00916584A EP 1165123 A4 EP1165123 A4 EP 1165123A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00916584A
Other languages
English (en)
French (fr)
Other versions
EP1165123A1 (de
Inventor
Craig A Rosen
Steven M Ruben
George Komatsoulis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1165123A1 publication Critical patent/EP1165123A1/de
Publication of EP1165123A4 publication Critical patent/EP1165123A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP00916584A 1999-03-26 2000-03-22 48 menschliche sekretierte proteine Withdrawn EP1165123A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12659599P 1999-03-26 1999-03-26
US126595P 1999-03-26
US17154999P 1999-12-22 1999-12-22
US171549P 1999-12-22
PCT/US2000/007525 WO2000057903A2 (en) 1999-03-26 2000-03-22 48 human secreted proteins

Publications (2)

Publication Number Publication Date
EP1165123A1 EP1165123A1 (de) 2002-01-02
EP1165123A4 true EP1165123A4 (de) 2002-09-11

Family

ID=26824840

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00916584A Withdrawn EP1165123A4 (de) 1999-03-26 2000-03-22 48 menschliche sekretierte proteine

Country Status (5)

Country Link
EP (1) EP1165123A4 (de)
JP (1) JP2002539811A (de)
AU (1) AU3766800A (de)
CA (1) CA2368442A1 (de)
WO (1) WO2000057903A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
EP1264842A4 (de) * 2000-02-21 2004-09-15 Kureha Chemical Ind Co Ltd Neue proteine und dafür kodierende gene
US7135559B2 (en) 2000-02-21 2006-11-14 Kureha Chemical Industry Co., Ltd. Proteins and novel genes encoding the same
CA2411971A1 (en) * 2000-06-16 2001-12-27 Incyte Genomics, Inc. Proteases

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792628A (en) * 1997-03-14 1998-08-11 Bowman; Michael Secreted protein, BA3.1, and polynucleotides encoding same
WO1998046756A1 (en) * 1997-04-16 1998-10-22 Millennium Biotherapeutics Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor
WO1998051790A1 (en) * 1997-05-13 1998-11-19 Amrad Operations Pty. Ltd. A novel nucleic acid molecule
EP0879887A1 (de) * 1997-05-21 1998-11-25 Smithkline Beecham Corporation Ein menschliches Gen mit Ähnlichkeit zum sekretierten Murinen Protein SDF5 (ATG-1622)
WO2000009525A2 (en) * 1998-08-03 2000-02-24 East Carolina University Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792628A (en) * 1997-03-14 1998-08-11 Bowman; Michael Secreted protein, BA3.1, and polynucleotides encoding same
WO1998046756A1 (en) * 1997-04-16 1998-10-22 Millennium Biotherapeutics Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor
WO1998051790A1 (en) * 1997-05-13 1998-11-19 Amrad Operations Pty. Ltd. A novel nucleic acid molecule
EP0879887A1 (de) * 1997-05-21 1998-11-25 Smithkline Beecham Corporation Ein menschliches Gen mit Ähnlichkeit zum sekretierten Murinen Protein SDF5 (ATG-1622)
WO2000009525A2 (en) * 1998-08-03 2000-02-24 East Carolina University Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 10 February 1999 (1999-02-10), XP002194741 *
DATABASE EMBL 12 November 1998 (1998-11-12), XP002194740 *
DATABASE EMBL 16 February 1998 (1998-02-16), XP002194739 *

Also Published As

Publication number Publication date
WO2000057903A2 (en) 2000-10-05
CA2368442A1 (en) 2000-10-05
AU3766800A (en) 2000-10-16
JP2002539811A (ja) 2002-11-26
EP1165123A1 (de) 2002-01-02

Similar Documents

Publication Publication Date Title
EP1218408A4 (de) 32 menschliche, sekretierte proteine
EP1212343A4 (de) 52 menschliche sekretierte proteine
EP1181390A4 (de) 27 menschliche, sekretierte proteine
EP1224285A4 (de) 27 menschliche sekretierte proteine
EP1212342A4 (de) 18 human-sekretierte proteine
EP1226231A4 (de) 19 humane sekretierte proteine
EP1175438A4 (de) 62 humane sekretierte proteine
EP1192176A4 (de) 49 menschliche sekretierte proteine
EP1192278A4 (de) 48 menschliche sekretierte proteine
EP1175439A4 (de) 49 humane sekretierte proteine
EP1165827A4 (de) 45 humane sekretierte proteine
EP1159284A4 (de) 33 human sekrteierte proteine
EP1189917A4 (de) 48 menschliche sekretierte proteine
EP1185543A4 (de) 50 human-sekretierte proteine
EP1224201A4 (de) 32 vom menschen abgesonderte proteine
EP1173477A4 (de) 49 humane sekretierte Proteine
EP1206573A4 (de) 26 humane sekretionsproteine
EP1203005A4 (de) 25 humane sekretierte proteine
EP1169332A4 (de) 49 human sekrtierte proteine
EP1165602A4 (de) 49 menschliche, sekretierte proteine
EP1144614A4 (de) Menschliche, ausgeschiedene proteine
EP1171460A4 (de) 48 menschliche sekretierte proteine
EP1165828A4 (de) 50 menschliche sekretierte proteine
EP1228082A4 (de) 29 humansekretierte proteine
EP1185285A4 (de) 49 humane sekretierte proteine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010927

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020725

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030715

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041014